OPEN-LABEL COMPARISON OF OLANZAPINE LONG-ACTING INJECTION AND ORAL OLANZAPINE: A 2-YEAR, RANDOMIZED STUDY IN OUTPATIENTS WITH SCHIZOPHRENIA

被引：0
|
作者：
Detke, Holland C. [1 ]
Weiden, Peter J. [2 ]
Llorca, P. M. [3 ]
Choukour, M. [4 ]
Watson, Susan B. [1 ]
Brunner, E. [1 ]
Ascher-Svanum, H. [1 ]
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA
[3] Ctr Hosp Univ, Psychiat Serv, Clermont Ferrand, France
[4] i3 Statprobe, Med Writing & Sci Commun, San Diego, CA USA
来源：
SCHIZOPHRENIA BULLETIN | 2011年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：300 / 300
页数：1
相关论文
共 50 条
  • [41] Childhood-onset schizophrenia: An open-label study of olanzapine in adolescents
    Kumra, S
    Jacobsen, LK
    Lenane, M
    Karp, BI
    Frazier, JA
    Smith, AK
    Bedwell, J
    Lee, P
    Malanga, CJ
    Hamburger, S
    Rapoport, JI
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1998, 37 (04): : 377 - 385
  • [42] Treatment completion rates of olanzapine and risperidone in long acting injectable formulations for the treatment of schizophrenia: A comparison of single arm open-label studies
    Ascher-Svanum, H.
    Montgomery, W.
    Brnabic, A.
    Lawson, A.
    Tomori, O.
    Coleman, K.
    Lynch, L.
    Chen, P.
    Andersen, S. W.
    McDonnell, D. P.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 161 - 162
  • [43] Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data
    Holland C Detke
    Fangyi Zhao
    Michael M Witte
    BMC Psychiatry, 12
  • [44] A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning
    Knegtering, H.
    Boks, Marco
    Blijd, Carl
    Castelein, Stynke
    Van den Bosch, Robert J.
    Wiersma, Durk
    JOURNAL OF SEX & MARITAL THERAPY, 2006, 32 (04) : 315 - 326
  • [45] Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data
    Detke, Holland C.
    Zhao, Fangyi
    Witte, Michael M.
    BMC PSYCHIATRY, 2012, 12
  • [46] OVERCOMING THE CHALLENGES OF MODELLING SCHIZOPHRENIA: A UK CASE STUDY OF THE COST-EFFECTIVENESS OF OLANZAPINE LONG-ACTING INJECTION VS. RISPERIDONE LONG-ACTING INJECTION
    Carroll, S. M.
    Jemiai, N.
    Moller, J.
    Novick, D.
    VALUE IN HEALTH, 2009, 12 (07) : A350 - A350
  • [47] Quality of life in the treatment of schizophrenia - A randomized, open-label comparison trial of amisulpride, olanzapine, quetiapine, risperidone and zotepine
    Lambert, M
    Moritz, S
    Karow, A
    Krausz, M
    Naber, D
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 176 - 176
  • [48] Olanzapine long-acting injection for the maintenance treatment of schizophrenia: A 24-week, randomized, double-blind trial
    Detke, H. C.
    McDonnell, D. P.
    Kane, J. M.
    Naber, D.
    Sethuraman, G.
    Lin, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 151 - 152
  • [49] Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
    Wehring, Heidi J.
    Thedford, Sheryl
    Koola, Maju
    Kelly, Deanna L.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2011, 3 : 107 - 123
  • [50] Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses
    Ciudad, Antonio
    Anand, Ernie
    Berggren, Lovisa
    Casillas, Marta
    Schacht, Alexander
    Perrin, Elena
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1737 - 1750
12345